Download PDF
Thromb Haemost 1993; 69(02): 205-213
DOI: 10.1055/s-0038-1651580
Scientific and Standardization Committee Communication
Schattauer GmbH Stuttgart

Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis

R L Edwards
The University of Connecticut School of Medicine and the American Red Cross Connecticut Region Blood Services, Farmington, CT, USA, and the Department of Veterans Affairs Medical Center, Newington, CT, USA
,
J Silver
The University of Connecticut School of Medicine and the American Red Cross Connecticut Region Blood Services, Farmington, CT, USA, and the Department of Veterans Affairs Medical Center, Newington, CT, USA
,
F R Rickles
The University of Connecticut School of Medicine and the American Red Cross Connecticut Region Blood Services, Farmington, CT, USA, and the Department of Veterans Affairs Medical Center, Newington, CT, USA
,
(for the Subcommittee) › Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Edwards RL, Morgan DL, Rickies FR. Animal tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemostas 1990; 63: 133-138
    PubMedGoogle Scholar
  • 2 Edwards RL, Rickies FR. Leukocytes and tumor cells in thrombosis. In: Hemostasis and Thrombosis. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) JB Lippincott; Philadelphia, PA: in press
  • 3 Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988; 72: 128-133
    PubMedGoogle Scholar
  • 4 Cozzolino F, Torcia M, Miliani A, Carossino AM, Giordani R, Cinotti S, Filimberti E, Saccardi R, Bernabei P, Guidi G, DiGug-lielmo R, Pistoia V, Ferrarini M, Nawroth PP, Stern D. Potential role of Interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med 1988; 84: 240-250
    CrossrefPubMedGoogle Scholar
  • 5 Dover R, Goeting NLM, Taylor I, Roath OS, Francis JL. Factor X-activating activity in patients with colorectal carcinoma. Br J Surg 1987; 74: 1122-1124
    CrossrefPubMedGoogle Scholar
  • 6 Bastida E, Ordinas A, Escolar G, Jamieson GA. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 1984; 64: 177-184
    PubMedGoogle Scholar
  • 7 Rana SV, Reimers HJ, Pathikonda MS, Bajaj SP. Expression of tissue factor and factor VII/tissue factor inhibitor activity in endotoxin or phorbal ester stimulated U937 monocyte-like cells. Blood 1988; 71: 259-262
    PubMedGoogle Scholar
  • 8 Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988; 71: 870-875
    PubMedGoogle Scholar
  • 9 Donati MB, Gambacorti-Passerini C, Casali B, Falanga A, Vannotti P, Fossati G, Semeraro N, Gordon SG. Cancer procoagulant in human tumor cells: Evidence frr melanoma patients. Cancer Res 1986; 46: 6471-6474
    PubMedGoogle Scholar
  • 10 Cajot JF, Kruithof EKO, Schleuning WD, Sordat B, Bachmann F. Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer 1986; 38: 719-727
    CrossrefPubMedGoogle Scholar
  • 11 Mussoni L, Conforti G, Gambacorti-Passerini C, Alessio G, Pepe M, Vaghi M, Erba E, Amato G, Landoni F, Mangione C, Morasca L, Semeraro N, Donati MB. Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. Eur J Clin Oncol 1986; 22: 373-380
    CrossrefPubMedGoogle Scholar
  • 12 Kitagawa H, Yamamoto N, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells. Cancer Res 1989; 49: 537-541
    PubMedGoogle Scholar
  • 13 Esumi N, Todo S, Imashuku S. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res 1987; 47: 2129-2135
    PubMedGoogle Scholar
  • 14 Grignani G, Falanga A, Pachiarini L, Alessio MG, Zucchella M, Fratino P, Donati MB. Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties. Int J Cancer 1988; 42: 554-557
    CrossrefPubMedGoogle Scholar
  • 15 Wijermans PW, Rebel VI, Ossenkoppele GJ, Huijgens PC, Langenhuijsen MMAC. Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemia cells: reversal of the bleeding disorder by cell differentiation. Blood 1989; 73: 800-805
    PubMedGoogle Scholar
  • 16 Curatolo L, Alessio G, Gambacorti-Passerini C, Casali B, Morasca L, Semeraro N, Donati MB. Procoagulant activity of mouse and human cultured cells following various types of transformation. Int J Cancer 1985; 35: 411-414
    CrossrefPubMedGoogle Scholar
  • 17 Guarini A, Gugliotta L, Timoncini C, Chetti L, Catani L, Russo D, Tura S. Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukemia. Scand J Haematol 1985; 34: 152-156
    PubMedGoogle Scholar
  • 18 Chorba TL, Orenstein JM, Ney AB, Schwartz BS, Alabaster O, Kessler CM, Cohen P, Schulof RS. Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity. Cancer 1985; 55: 675-681
    CrossrefPubMedGoogle Scholar
  • 19 Gralnick HR, Abrell E. Studies of the Procoagulant and the fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Br J Haematol 1973; 24: 89-99
    CrossrefPubMedGoogle Scholar
  • 20 Rickies FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 1983; 62: 14-31
    PubMedGoogle Scholar
  • 21 Dvorak HF, Van DeWater L, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, DeWolf W, Carvalho ACA. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983; 43: 4334-4342
    PubMedGoogle Scholar
  • 22 Hudig D, Bajaj SP. Tissue factor-like activity of the human monocytic tumor cell line U937. Thromb Res 1982; 27: 321-322
    CrossrefPubMedGoogle Scholar
  • 23 Sakuragawa N, Takahashi K, Hoshiyama M, Jimbo C, Ashizawa K, Matsuoka M, Ohnishi Y. The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome. Thromb Res 1977; 10: 457-463
    CrossrefPubMedGoogle Scholar
  • 24 Ewan VA, Edwards RL, Rickies FR. Expression of procoagulant activity in a human monocyte like cell line. J Lab Clin Med 1983; 101: 401-410
    PubMedGoogle Scholar
  • 25 Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. Thromb Res 1975; 6: 127-137
    CrossrefPubMedGoogle Scholar
  • 26 Gordon SG, Gilbert LC, Lewis BJ. Analysis of PC A of intact cells from tissue culture. Thromb Res 1982; 26: 379-387
    CrossrefPubMedGoogle Scholar
  • 27 Pineo AF, Brain MC, Gallus AS, Hirsh J, Hatton MWC, Regoeczi E. Tumors, mucus production and hypercoagulability. Ann NY Acad Sci 1974; 230: 262-270
    CrossrefPubMedGoogle Scholar
  • 28 Sakuagawa N, Takahashi K, Hoshiyama M, Jimbo C, Matsuoka M, Onishi Y. Pathologic cells as procoagulant substance of disseminated intravascular coagulation in acute promyelocytic leukemia. Thromb Res 1976; 8: 263-273
    CrossrefPubMedGoogle Scholar
  • 29 Kinjo M, Oka K, Naito S, Kohga S, Tanaka K, Oboshi S, Hayaka Y, Yasumoto K. Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br J Cancer 1979; 39: 15-23
    CrossrefPubMedGoogle Scholar
  • 30 O’Meara RAQ, Thornes RD. Some properties of the cancer coagulative factor. Irish J Med Sci 1961; 423: 106-112
    PubMedGoogle Scholar
  • 31 Boggust WA, O’Brien DJ, O’Meara RAQ, Thornes RD. The coagulative factors of normal human and human cancer tissue. Irish J Med Sci 1963; 447: 131-144
    PubMedGoogle Scholar
  • 32 Svanberg L. Thromboplastic activity of human ovarian tumours. Thromb Res 1975; 6: 307-313
    CrossrefPubMedGoogle Scholar
  • 33 Gordon SG, Franks JJ, Lewis BJ. Comparison of procoagulant activity in extracts of normal and malignant human tissue. J Natl Cancer Inst 1979; 62: 773-778
    PubMedGoogle Scholar
  • 34 Karhumaki E, Saravo L, Helin H. Cells of the human myelomonocytic cell line RC2A synthesize tissue factor-like procoagulant and urokinase type plasminogen activator. J Leuk Biol 1987; 42: 36-42
    CrossrefPubMedGoogle Scholar
  • 35 Fair DS, MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 1987; 262: 11692-11698
    PubMedGoogle Scholar
  • 36 Geczy CL, Jones A. Procoagulant induction by human lymphokine and interferon ϒ/PMA on a myelomonocytic cell line, RC2a. Br J Haematol 1988; 70: 211-218
    CrossrefPubMedGoogle Scholar
  • 37 Kornberg A, Treves A, Rachmilewitz EA, Fibach E. Generation of procoagulant activity (PCA) by phorbol-esters-induced macrophage derived from a leukemic promyelocytic cell line (HL60). Blood 1982; 59: 1061-1066
    PubMedGoogle Scholar
  • 38 Grignani G, Jamieson GA. TF-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line. Invasion Metastasis 1987; 7: 172-182
    PubMedGoogle Scholar
  • 39 Gambarcorti-Passerini C, Semeraro N, Pourli MD, Gordon SG. Cancer procoagulant and haemostatic abnormalities in melanoma. Lancet 1986; 1: 920
    PubMedGoogle Scholar
  • 40 Gouault-Heilmann M, Chadon E, Sultan C, Josso F. The procoagulant factor of leukemic promyelocytes. Demonstration of immunologic cross reactivity with human brain tissue factor. Br J Haematol 1975; 30: 151-158
    CrossrefPubMedGoogle Scholar
  • 41 Tanaka M. Induction of tissue factor like activity of human monoblastic leukemia cell line by tumor necrosis factor-alpha. Thromb Res 1989; 56: 201-211
    CrossrefPubMedGoogle Scholar
  • 42 Barrowcliffe TW, Marshall DE, Trickett LP, Hubbard AR, Gray E, Thorpe R. Procoagulant activity of T-lymphoblastoid cells in extrinsic and intrinsic coagulation systems. Thromb Haemostas 1989; 62: 880-894
    PubMedGoogle Scholar
  • 43 Silberberg JM, Gordon S, Zucker S. Identification of tissue factor into pancreatic cancer cell lines. Cancer Res 1989; 49: 5443-5447
    PubMedGoogle Scholar
  • 44 Viero P, Cortelazzo S, Barbui T, Semeraro N. Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol esters. Eur J Clin Cancer Oncol 1986; 22: 857-862
    PubMedGoogle Scholar
  • 45 Sakai T, Lund-Hansen T, Parborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). J Biol Chem 1989; 17: 9980-9988
    PubMedGoogle Scholar
  • 46 Kubota T, Andoh K, Sadakata H, Tanaka H, Kobayashi N. Tissue factor released from leukemic cells. Thromb Haemostas 1991; 65: 59-63
    PubMedGoogle Scholar
  • 47 Donati MB, Falanga A, Consonni R, Alessio MG, Bassan R, Buelli M, Borin L, Catani L, Pogliani E, Gugliotta L. et al. Cancer procoagulant in acute non-lymphoid leukemia: relationship of enzyme detection to disease activity. Thromb Haemostas 1990; 64: 11-16
    PubMedGoogle Scholar
  • 48 Alessio MG, Falanga A, Consonni R, Bassan R, Minetti B, Donati MB, Barbui T. Cancer procoagulant in acute lymphoblastic leukemia. Eur J Haematol 1990; 45: 78-81
    PubMedGoogle Scholar
  • 49 Bauer KA, Conway EM, Bach R, Konigsberg WH, Griffin JD, Demetri G. Tissue gene expression in acute myeloblastic leukemia. Thromb Res 1989; 56: 425-430
    CrossrefPubMedGoogle Scholar
  • 50 Sakai T, Kisiel W. Binding of human factors X and Xa to HepG2 and J82 human tumor cells. J Biol Chem 1990; 265: 9105-9113
    PubMedGoogle Scholar
  • 51 Parmar J, Taylor I, Roath S, Francis J. Procoagulant activity in whole blood from patients with breast and colorectal cancer. Blood Coag Fibrinolys 1990; 1: 127-132
    PubMedGoogle Scholar
  • 52 el-Baruni K, Taylor I, Roath S, Francis JL. Factor X-activating procoagulant in normal and malignant breast tissue. Hematol Oncol 1990; 8: 323-332
    CrossrefPubMedGoogle Scholar
  • 53 Pacchiarini L, Meloni F, Zucchella M, Mangiarotti P, Tacconi F, Ballabio P, Grignani G. Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of “in vitro” culture. Haematologica 1991; 76: 392-397
    PubMedGoogle Scholar
  • 54 Celladurai M, Honn KV, Walz Da. HLA-DR is procoagulant. Biochem Biophys Res Commun 1991; 178: 467-473
    CrossrefPubMedGoogle Scholar